Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation
出版年份 2019 全文链接
标题
Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation
作者
关键词
-
出版物
CELL CYCLE
Volume 18, Issue 15, Pages 1770-1783
出版商
Informa UK Limited
发表日期
2019-06-26
DOI
10.1080/15384101.2019.1632640
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
- (2019) Jordan Guillon et al. Cell Death & Disease
- Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence
- (2018) Guillaume Collin et al. Cell Death & Disease
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- Context-dependent effects of cellular senescence in cancer development
- (2016) Pacome Lecot et al. BRITISH JOURNAL OF CANCER
- Optimize and refine therapeutic index in radiation therapy: Overview of a century
- (2016) Cyrus Chargari et al. CANCER TREATMENT REVIEWS
- Senescence: Adaptation to DNA repair targeting drugs?
- (2016) Olivier Coqueret CELL CYCLE
- Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?
- (2016) Brian Budke et al. ChemMedChem
- Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells
- (2016) Moureq Alotaibi et al. RADIATION RESEARCH
- Tumor Cell Recovery from Senescence Induced by Radiation with PARP Inhibition
- (2016) David A. Gewirtz et al. RADIATION RESEARCH
- Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51
- (2015) Ambber Ward et al. CANCER TREATMENT REVIEWS
- Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells
- (2015) Hongyu Ma et al. Radiation Oncology
- Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
- (2015) Barbara Jonchère et al. Oncotarget
- Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells
- (2015) Kathleen A. Bridges et al. Oncotarget
- A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts
- (2014) Fei Huang et al. PLoS One
- A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
- (2014) David A. Alagpulinsa et al. Frontiers in Oncology
- Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer
- (2013) Judith Michels et al. CELL CYCLE
- Mechanisms of resistance to therapies targeting BRCA-mutant cancers
- (2013) Christopher J Lord et al. NATURE MEDICINE
- Charged particle therapy—optimization, challenges and future directions
- (2013) Jay S. Loeffler et al. Nature Reviews Clinical Oncology
- Low-LET Proton Irradiation of A549 Non-small Cell Lung Adenocarcinoma Cells: Dose Response and RBE Determination
- (2013) Anne-Catherine Wéra et al. RADIATION RESEARCH
- Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: Survival curves and gene expression profiles
- (2013) Hélène Riquier et al. RADIOTHERAPY AND ONCOLOGY
- A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
- (2012) Katharina Schlacher et al. CANCER CELL
- PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells
- (2012) H. Cheng et al. CARCINOGENESIS
- Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase
- (2012) Fei Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor
- (2012) Louise J Barber et al. JOURNAL OF PATHOLOGY
- Past, present and future of radiotherapy for the benefit of patients
- (2012) Juliette Thariat et al. Nature Reviews Clinical Oncology
- The combination of olaparib and camptothecin for effective radiosensitization
- (2012) Katsutoshi Miura et al. Radiation Oncology
- Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer
- (2012) Ashish Juvekar et al. Cancer Discovery
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening
- (2011) Fei Huang et al. ACS Chemical Biology
- Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft
- (2011) J. M. Senra et al. MOLECULAR CANCER THERAPEUTICS
- In vitro irradiation station for broad beam radiobiological experiments
- (2011) A.-C. Wéra et al. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- Radiation-induced cell death mechanisms
- (2010) David Eriksson et al. TUMOR BIOLOGY
- Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
- (2009) Florence Debacq-Chainiaux et al. Nature Protocols
- Charged particles in radiation oncology
- (2009) Marco Durante et al. Nature Reviews Clinical Oncology
- Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential
- (2008) Fiona A. Dungey et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now